Consistently, early genetic manipulations [190,191] or viral-mediated gene therapy [192,193] demonstrated that reducing the expression of this harmful protein in astrocytes slowed motor decline and prolonged survival in mouse models of ALS-SOD1. Here, SOD1 is linked to amyotrophic lateral sclerosis.